News
Nasal decongestant sprays that contain oxymetazoline or xylometazoline – which belong to a classification of drugs known as alpha-sympathomimetics – can almost paralyze the cilia in the mucus ...
The Momcozy Nasal Aspirator is designed to address common congestion issues in infants and young children, particularly ...
Aug. 9, 2024 – An epinephrine nasal spray to treat serious allergic reactions may soon be available in the U.S. The FDA announced its approval of the nasal spray, called neffy, on Friday.
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
If nasal polyps are present in these individuals, a healthcare professional may test for other conditions, ... either on their own or for taking along with a nasal spray.
The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
The Food and Drug Administration approved Johnson & Johnson's nasal spray to be used alone in adults with a major depressive disorder that is difficult to treat, as sales of the drug grow.
Hosted on MSN1mon
Mosanna Therapeutics gains $80m to advance OSA nasal spray - MSNThe company is developing MOS118, an easy-to-use nasal spray for OSA that helps restore the body's natural airway control. Pivotal bioVenture Partners and EQT Life Sciences headed the financing.
Chris Diaz, age 8, receives a H1N1 nasal flu spray vaccine from a nurse in Miami, Florida, in October 2009. The Centers for Disease Control and Prevention recommends that everyone six months and ...
The epinephrine nasal spray, called Neffy, offers an alternative to EpiPen injections and is approved for adults and children who weigh at least 30 kilograms (about 66 pounds), said the FDA in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results